Prothena (NASDAQ:PRTA) PT Lowered to $24.00
Prothena (NASDAQ:PRTA – Free Report) had its price target reduced by Royal Bank of Canada from $28.00 to $24.00 in a report released on Friday, Benzinga reports. Royal Bank of Canada currently has a sector perform rating on the biotechnology company’s stock. A number of other equities analysts have also recently issued reports on the […]
More Stories
Ajinomoto (OTCMKTS:AJINY) Shares Cross Below 50 Day Moving Average – Should You Sell?
Ajinomoto Co., Inc. (OTCMKTS:AJINY – Get Free Report)’s stock price crossed below its 50-day moving average during trading on Friday...
Frenkel Topping Group (LON:FEN) Share Price Passes Below 50 Day Moving Average – Time to Sell?
Frenkel Topping Group Plc (LON:FEN – Get Free Report)’s share price crossed below its 50-day moving average during trading on...
Saker Aviation Services (OTCMKTS:SKAS) Shares Cross Below 50 Day Moving Average – Here’s What Happened
Saker Aviation Services, Inc. (OTCMKTS:SKAS – Get Free Report)’s share price passed below its fifty day moving average during trading...
Kentucky First Federal Bancorp (NASDAQ:KFFB) Stock Price Crosses Below 200-Day Moving Average – Time to Sell?
Kentucky First Federal Bancorp (NASDAQ:KFFB – Get Free Report) shares passed below its 200-day moving average during trading on Friday...
FLYHT Aerospace Solutions (CVE:FLY) Stock Crosses Above Fifty Day Moving Average – Should You Sell?
FLYHT Aerospace Solutions Ltd. (CVE:FLY – Get Free Report)’s stock price passed above its fifty day moving average during trading...
Royce Micro-Cap Trust (NYSE:RMT) Shares Pass Above 50-Day Moving Average – Should You Sell?
Royce Micro-Cap Trust, Inc. (NYSE:RMT – Get Free Report)’s share price passed above its 50 day moving average during trading...